COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 25
Cardiovascular Tissues
411
Gastrointestinal Tissues
411
Clinical Significance of Array 5
412
Early Intervention Opportunity
414
Monitoring Treatment Efficacy
414
Who Should Consider Array 5
414
Family History of Autoimmunity
414
Early Symptoms Without Diagnosis
414
Established Autoimmune Disease
415
Intestinal Permeability
415
Unexplained Inflammatory Symptoms
415
Conditions Where Array 5 is Especially Valuable
415
Autoimmune Reversibility Factors
417
Stage of Autoimmune Process
417
Antibody Titers and Patterns
417
Underlying Trigger Identification
417
Comprehensive Intervention Strategies
418
Intestinal Barrier Healing
418
Environmental Trigger Removal
418
Immune Modulation
418
Anti-Inflammatory Protocol
418
Success Rates and Timelines
419
Antibody Reduction Timelines
419
Symptom Improvement
419
Long-Term Outcomes
419
Clinical Integration of Array 5 with Other Testing
421
25
